Neostigmine
These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE. NEOSTIGMINE METHYLSULFATE injection, for intravenous use Initial U.S. Approval: 1939
Approved
Approval ID
95fb1b3d-be9a-fdb4-e053-2a95a90a5e90
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 15, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Neostigmine
PRODUCT DETAILS
NDC Product Code71872-7178
Application NumberANDA209135
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMay 15, 2023
Generic NameNeostigmine
INGREDIENTS (6)
PHENOLInactive
Quantity: 4.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM ACETATEInactive
Quantity: 0.2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
NEOSTIGMINE METHYLSULFATEActive
Quantity: 1 mg in 1 mL
Code: 98IMH7M386
Classification: ACTIB